Results 251 to 260 of about 1,336,088 (341)

Impact of Location of Residence and Distance to Cancer Centre on Medical Oncology Consultation and Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer. [PDF]

Curr Oncol
Yee EK, Hallet J, Look Hong NJ, Nguyen L, Coburn N, Wright FC, Gandhi S, Jerzak KJ, Eisen A, Roberts A.   +9 more
europepmc   +1 more source

Breast Cancer Presentations at Benghazi Medical Center Oncology Department, 2020-2023 [PDF]

Randa Masood Elsehati, Abeer Hussein Amer, Elie Najem, Wael Abdel-Razek AlFarjani, Aisha Khamis AlArfi, Mawada Mohamed Alshaykhi, Sufyan Mohammed AlGhuwail, Department of Cytotechnology, Faculty of Biomedical Sciences, University of Benghazi, Benghazi, Libya., Aisha Khamis AlArfi, Department of Cytotechnology, Faculty of Biomedical Sciences, University of Benghazi, Benghazi, Libya., Mawada Mohamed Alshaykhi, Department of Cytotechnology, Faculty of Biomedical Sciences, University of Benghazi, Benghazi, Libya., Sufyan Mohammed AlGhuwail, Department of Cytotechnology, Faculty of Biomedical Sciences, University of Benghazi, Benghazi, Libya.   +13 more
openalex   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

EXclusion of non-Involved uterus from the Target Volume (EXIT-trial): An individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques : 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 11 Medical and Health Sciences 1103 Clinical Sciences

, 2018
Katrien Vandecasteele, Philippe Tummers, M. vanBockstal, Pieter De Visschere, Tom Vercauteren, W. deGersem, Hannelore Denys, E. Naert, Adel Makar, W. deNeve   +9 more
openalex   +1 more source

A Curriculum in Oncology for Medical Students in Europe

, 1989
Michael Peckham
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology. [PDF]

Clin Transl Oncol
Guillot Morales M, Visa L, Brozos Vázquez E, Feliu Batlle J, Khosravi Shahi P, Laquente Sáez B, de San Vicente Hernández BL, Macarulla T, Gironés Sarrió R.   +8 more
europepmc   +1 more source

Methotrexate in the treatment of osteosarcoma in children and adolescents: the experience of the musculoskeletal sarcoma research group of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

E. I. Konopleva, Alexander Karachunskiy, О. И. Быданов, G. А. Novichkova   +3 more
openalex   +2 more sources

IMPLEMENTATION OF TQM PRINCIPLES IN THE SYSTEM OF INTERNAL QUALITY AND SAFETY CONTROL OF MEDICAL PRACTICE ON THE EXAMPLE OF SAMARA REGIONAL CLINICAL ONCOLOGY DISPENSARY

, 2016
А Е Орлов, В В Павлов, О А Прошина   +2 more
openalex   +2 more sources

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source